Molecular Docking and Molecular Dynamics Simulation using Monascus sp. as a Candidate Cervical Cancer Drug

Authors

  • Anna Yuliana Department of Pharmacy, Bakti Tunas Husada University, Tasikmalaya, West Java, Indonesia https://orcid.org/0000-0001-5516-9303
  • Ira Rahmiyani Department of Pharmacy, Bakti Tunas Husada University, Tasikmalaya, West Java, Indonesia https://orcid.org/0000-0003-3763-4405
  • Cindi Kartika Department of Pharmacy, Bakti Tunas Husada University, Tasikmalaya, West Java, Indonesia

DOI:

https://doi.org/10.25026/jtpc.v7i1.432

Keywords:

Monascus, Cervical cancer, Docking, Molecular Dynamics

Abstract

Cervical cancer is the fourth most common female cancer worldwide and results in over 300000 deaths globally. Given that HPV prophylactic vaccines do not exert a therapeutic effect in individuals previously infected, it is unlikely that HPV-associated cancers will be eradicated in the coming years. Therefore, there is an emerging need for the development of anti-HPV drugs. The purpose of this study is to find out Monascus sp. as cervical anticancer using molecular docking and dynamics methods. The results of docked with AutodockTools were visualized with Pymol, analyzed the effectiveness using the Ramachandran plot. The docking results show that there are 2 pigments that have lower G than raloxifen in estrogen receptor beta with the lowest G indicated by the pigment Monascin and Ankaflavin, which is -6.94 kcal/mol with Ki value of 39.49 nM and -6.22 kcal/mol with Ki value of 27.78 nM. The results of molecular dynamics, Ankaflavin and Monascin have good stability at estrogen receptor beta because the outlier area has a value 11.722% and 10.256%. And the amino acid residues in the most preferred area were 68.864% and 70.330%. In addition, Monascopyridine B and Monascuspiloin pigments showed good and stable results at the EGFR receptor because the outlier areas were 14.692% and 10.623%. And the amino acid residues in the most-favored region were 65.403% and 73.260%. Based on the results of this study, we predict that Ankaflavin, Monascin, Monascopyridine B and Monascuspiloin can be used as new cervical anticancer candidates after validated with in vitro and in vivo tests.

Downloads

Download data is not yet available.

References

N. Bhatla, D. Aoki, D. Nand, And S. Rengaswamy, “Cancer Of The Cervix Uteri,” Figo Cancer Rep., Vol. 143, Pp. 22–36, 2018, Doi: 10.1002/Ijgo.12611.

C. De Martel, M. Plummer, J. Vignat, And S. Franceschi, “Worldwide Burden Of Cancer Attributable To Hpv By Site, Country And Hpv Type,” Int. J. Cancer, Vol. 141, Pp. 1–22, 2017.

S. . I. Bruni, L., et.al, “Human Papillomavirus And Related Diseases Report,” Hpv Inf. Cent., No. October, 2021.

M. Ahmad, “Karakteristik Ibu Yang Melakukan Pemeriksaan Pap Smear Di Rspad Gatot Soebroto , Jakarta,” J. Ilmu Kesehat. Masy., Vol. 05, No. 01, Pp. 1–4, 2016.

A. Yuliana., et.al, “Studi In Silico Metabolit Sekunder Kapang Monascus sp. sebagai Kandidat Antikolesterol dan Antikanker,” Alchemy Jurnal Penelitian Kimia, Vol. 15 (1) : 104-123. 2019.

A. Allouche, D. Lyon, And F.- Lyon, “Software News And Updates Gabedit — A Graphical User Interface For Computational Chemistry Softwares,” J. Comput. Chem., Vol. 32, No. 1, Pp. 174–180, 2010, Doi: 10.1002/Jcc.

Tomalia, A. D. Et Al. ‘The Role Of Branch Cell Symmetry And Other Critical Nanoscale Design Parameters In The Determination Of Dendrimer Encapsulation Properties’, Biomolecules, 10(642), Pp. 1–56. 2020. Doi:10.3390/Biom10040642.

A. Yuliana And F. Apriyani, “Isolasi Zat Warna Baru Monascus Purpureus Dari Hasil Fermentasi Padat Dengan Beras Sebagai Substrat,” J. Pharmacopolium, Vol. 1, No. 1, Pp. 13–22, 2018.

Ruswanto, “Molecular Docking Empat Turunan Isonicotinohydrazide Pada Mycobacterium Tuberculosis Enoyl-Acyl Carrier Protein Reductase (Inha),” J. Kesehat. Bakti Tunas Husada, Vol. 13, No. 1, Pp. 135–140, 2016, Doi: 10.36465/Jkbth.V13i1.25.

R. Prasetiawati, B. Permana, D. Soni, And S. N. Agung, “Molecular Docking Study Of Xanthone Derivative Compounds Of Mangosteen Rind (Garcinia Mangostana L.) To Er-? (Estrogen Receptor Alfa) And Er-? (Estrogen Receptor Beta) As Anti-Breastcancer,” Farm. Bahari, Vol. 10, No. 1, Pp. 45–52, 2019.

C. A. Lipinski, F. Lombardo, B. W. Dominy, And P. J. Feeney, “Experimental And Computational Approaches To Estimate Solubility And Permeability In Drug Discovery And Development Settings I,” Adv. Drug Deliv. Rev., Vol. 64, Pp. 4–17, 2012, Doi: 10.1016/J.Addr.2012.09.019.

F. Z. Muttaqin, H. Ismail, And H. N. Muhammad, “Studi Molecular Docking, Molecular Dynamic, Dan Prediksi Toksisitas Senyawa Turunan Alkaloid Naftiridin Sebagai Inhibitor Protein Kasein Kinase 2-? Pada Kanker Leukemia,” Pharmacoscript, Vol. 2, No. 1, Pp. 49–60, 2019.

M. B. O. Rastini, N. K. M. Giantari, K. D. Adnyani, “Molecular Docking Aktivitas Antikanker Dari Kuersetin Terhadap Kanker Payudara Secara In Silico,” JCHEM, vol. 13, no. 02, pp. 180–183, 2019, doi: https://doi.org/10.24843/.

U. S. F. Tambunan, A. A. Parikesit, A. S. Ghifari, and C. P. Satriyanto, “In silico identification of 2-oxo-1 , 3-thiazolidine derivatives as novel inhibitor candidate of class II histone deacetylase ( HDAC ) in cervical cancer treatment,” Arab. J. Chem., vol. 30, no. 3, pp. 31–35, 2015, doi: 10.1016/j.arabjc.2015.07.010.

Lone IH, Khan KZ, Fozdar BI. Synthesis, physicochemical properties, antimicrobial and antioxidant studies of pyrazoline derivatives bearing a pyridyl moiety. Med Chem Res. 2014;23(1):363-369. DOI: 10.1007/s00044-013-0643-z.

Ruswanto. "Molecular Docking Simulation of Neuraminidase Influenza A Subtype H1N1 with Potential Inhibitor of Disulfide Cyclic Peptide (DNY, NNY, LRL)". IOP Conf. Series: Materials Science and Engineering, 349, pp 1-6. 2019. doi:10.1088/1757-899X/349/1/012052.

Kelutur. ‘In Silico Docking to Explicate Interface between Plant-Originated Inhibitors and E6 Oncogenic Protein of Highly Threatening Human Papillomavirus 18’, Genomics Inform, 13(2), pp. 60–67. 2016. DOI:10.5808/GI.2015.13.2.60.

Cozza, Giorgio. (2017) ‘TheDevelopment of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design’, Pharmaceuticals, 10 (26). 2017. Doi:10.3390/ph10010026.

Fitriah. "In Silico Prediction of Isoliquiritigenin and Oxyresveratrol Compounds to BCL-2 dan VEGF-2 Receptors". Indonesian Journal of Cancer Chemoprevention, 10(2), pp 51-59. 2019. ISSN: 2088–0197.

Glowacki. "Computational Biochemistry and Biophysics", pp. 1–30. 2001. ISBN 9780367397579.

Lins L, Brasseur R. "The hydrophobic effect in protein folding". Faseb J. 9: 535- 540.1995.

Effendy.Teori VSEPR Kepolaran, dan Gaya Antarmolekul. Bayumedia Publishing, Malang. 2006.

Lins L, Brasseur R. The Hydrophobic Effect in Protein Folding. Faseb J. 1995. 9: 535-540.

Ruswanto, Mardianingrum R, Novitriani K. "Sintesis Dan Studi in Silico Senyawa 3-NitroN’-[(Pyridin-4-YI)Carbonyl] Benzohydrazide Sebagai Kandidat Antituberkulosis". Chimica et Natura Acta. 3(2). 2015. doi:10.1098/1757-899X/349/1/012052.

Cosconati, S., S.Forli, A.L.Perryman, R.Harris, D.S.Goodsell, A.J.Olson. "Virtual Screening with AutoDock : Theory and Practice. Expert Opinion Drug Discovery". 2010. Vol 5. No 6. 597-607.

W. Saleh, “Studi Hubungan Kuantitatif Struktur- Studi Hubungan Kuantitatif Struktur- Aktivitas AntiTuberkulosis Senyawa Amidasi Etil P-Metoksisinamat Dengan Pendekatan Hansch dan Penambatan Molekuler Pada Enzim Inh A,” pp. 1–101, 2015.

Amelia, F., & Darmadja, S. "Konfirmasi Faktor yang Berpengaruh terhadap Pengambilan Keputusan dalam Pemenuhan Nutrisi Ibu Hamil". Citra Delima, 2(2): 101-110. 2019. doi:10.33862/citradelima.v2i2.37.

Downloads

Published

2023-06-29

How to Cite

Yuliana, A., Rahmiyani, I., & Kartika, C. (2023). Molecular Docking and Molecular Dynamics Simulation using Monascus sp. as a Candidate Cervical Cancer Drug. Journal of Tropical Pharmacy and Chemistry, 7(1), 41–51. https://doi.org/10.25026/jtpc.v7i1.432